TipRanks
Delorean Corporation Ltd (AU:DEL)
ASX:DEL
Australian Market
Want to see AU:DEL full AI Analyst Report?

Delorean Corporation Ltd (DEL) AI Stock Analysis

20 Followers

Top Page

AU:DEL

Delorean Corporation Ltd

(Sydney:DEL)

Select Model
Select Model
Select Model
Neutral 45 (OpenAI - Gpt-5.6Sol)
Rating:45Neutral
Price Target:
AU$0.09
▼(-12.00% Downside)
Action:Reiterated
Date:09/26/26
The score is primarily weighed down by weak financial performance: sharp revenue contraction, ongoing negative margins, heavy free-cash-flow burn, and significantly increased leverage. Technical indicators provide only modest support (mixed trend with some near-term momentum), while valuation is difficult to justify given the company remains loss-making and no dividend yield is available.
Positive Factors
Biogas Infrastructure Focus
The focus on capturing biogas from waste and wastewater facilities targets a structural need to reduce methane emissions while producing renewable electricity. Developing, owning and operating infrastructure can support recurring asset-based revenue as projects become operational.
Negative Factors
Sharp Revenue Contraction
Two consecutive years of revenue decline indicate weakened business scale and make it harder to absorb fixed project and operating costs. Continued contraction could reduce internally generated funding, limit investment capacity, and delay a return to sustainable profitability.
Read all positive and negative factors
Positive Factors
Negative Factors
Biogas Infrastructure Focus
The focus on capturing biogas from waste and wastewater facilities targets a structural need to reduce methane emissions while producing renewable electricity. Developing, owning and operating infrastructure can support recurring asset-based revenue as projects become operational.
Read all positive factors

Delorean Corporation Ltd (DEL) vs. iShares MSCI Australia ETF (EWA)

Delorean Corporation Ltd Business Overview & Revenue Model

Company Description
Delorean Corporation Limited is an Australian enterprise deeply involved in the renewable energy and waste management industries across both Australia and New Zealand. Its comprehensive business model is segmented into Infrastructure, Engineering,...
How the Company Makes Money
Delorean Corporation’s revenue model is based on monetising biogas and the energy and environmental attributes derived from it. Key revenue streams include: (1) electricity generation revenue from converting captured biogas into power and selling ...

Delorean Corporation Ltd Financial Statement Overview

Summary
Financial health is weak. Revenue fell sharply (~40% in FY2026 after a decline in FY2025), profitability remains negative (negative gross profit and deeply negative operating margins in FY2025–FY2026), cash burn is substantial with consistently negative free cash flow (including ~-22.8M in FY2026), and leverage has risen materially with very high debt-to-equity (~6.6x in FY2026). Losses narrowed in FY2026 versus FY2025, but the company has not returned to the stronger FY2024 profile.
Income Statement
22
Negative
Balance Sheet
28
Negative
Cash Flow
16
Very Negative
BreakdownJun 2026Jun 2025Jun 2024Jun 2023Jun 2022
Income Statement
Total Revenue8.54M19.83M27.88M19.25M39.33M
Gross Profit-3.25M-2.99M7.83M-7.18M-6.77M
EBITDA-4.03M-6.13M5.04M-9.06M-11.87M
Net Income-916.03K-6.55M4.77M-10.02M-10.89M
Balance Sheet
Total Assets62.97M48.30M28.05M17.92M24.10M
Cash, Cash Equivalents and Short-Term Investments5.41M10.66M8.84M1.00M3.12M
Total Debt49.89M31.31M9.07M7.62M2.63M
Total Liabilities55.35M40.45M19.28M15.75M12.21M
Stockholders Equity7.51M7.85M8.77M2.17M11.88M
Cash Flow
Free Cash Flow-22.83M-21.50M6.89M-6.80M-15.21M
Operating Cash Flow-1.69M-5.66M7.24M-5.36M-11.77M
Investing Cash Flow-19.34M-15.08M-3.92M-1.44M-3.44M
Financing Cash Flow17.29M23.33M915.22K4.68M5.26M

Delorean Corporation Ltd Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.10
Price Trends
50DMA
0.09
Negative
100DMA
0.09
Negative
200DMA
0.10
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
38.72
Neutral
STOCH
-15.44
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:DEL, the sentiment is Negative. The current price of 0.1 is above the 20-day moving average (MA) of 0.09, above the 50-day MA of 0.09, and above the 200-day MA of 0.10, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 38.72 is Neutral, neither overbought nor oversold. The STOCH value of -15.44 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:DEL.

Delorean Corporation Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (66)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
66
Neutral
$17.65B18.105.60%3.62%6.62%11.55%
59
Neutral
AU$62.41M3.6465.86%―――
58
Neutral
AU$20.38M11.2612.83%―57.73%30.59%
50
Neutral
AU$157.04M-11.24-718.72%―27.74%49.26%
47
Neutral
AU$76.91M-27.14-14.42%―42.98%-9.38%
45
Neutral
AU$21.25M-20.24-16.09%―-52.16%96.81%
45
Neutral
AU$37.15M-3.31-138.53%――-29.75%
* Utilities Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:DEL
Delorean Corporation Ltd
0.08
-0.07
-44.67%
AU:CCE
Carnegie Clean Energy Ltd
0.19
0.09
80.95%
AU:JNS
ReNu Energy Limited
0.85
0.68
400.00%
AU:KPO
Kalina Power Limited
0.02
<0.01
42.86%
AU:14D
1414 Degrees Ltd.
0.05
0.02
62.50%
AU:VPR
Volt Power Group Ltd
0.13
-0.01
-7.41%

Delorean Corporation Ltd Corporate Events

Delorean and Opal Advance $35m Bioenergy Project at Maryvale Mill
Sep 22, 2026
Delorean Corporation and Paper Australia&#8217;s Opal have completed the Concept Stage of their collaboration to develop a bioenergy facility at Opal&#8217;s Maryvale Mill in Victoria, advancing plans to convert organic residues and paper by-produ...
Delorean advances BOO renewable gas strategy as losses narrow and assets grow
Aug 31, 2026
Delorean reported FY26 revenue of $8.5 million, down 56% from FY25, but delivered a positive EBITDA of $0.18 million and cut its total comprehensive loss after tax to $0.9 million, an 86% improvement. Total assets rose to $63 million and cash and ...
Delorean boosts funding as key renewable gas projects advance toward delivery
Jul 31, 2026
Delorean Corporation reported a cash balance of $5.6 million at 30 June 2026, supported by $1.06 million in customer receipts and a $5.76 million RD tax refund that underpins ongoing bioenergy infrastructure development. The company also completed...
Delorean secures third ARENA milestone payment for SA1 Salisbury bioenergy plant
Jul 12, 2026
Delorean Corporation has received a third milestone payment of $1.66 million from the Australian Renewable Energy Agency, bringing total grant receipts to $5.46 million under a $7.74 million funding agreement. The financing supports the developmen...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 26, 2026